These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22139885)

  • 1. The peptide derived from erbB2 auto-inhibitor herstatin shared in the same epitope and function with functional antibody 2C4.
    Lv M; Qiao C; Jiang N; Li X; Yu M; Hou C; Li Y; Feng J; Shen B
    Mol Biotechnol; 2012 Jun; 51(2):174-82. PubMed ID: 22139885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4.
    Albanell J; Codony J; Rovira A; Mellado B; Gascón P
    Adv Exp Med Biol; 2003; 532():253-68. PubMed ID: 12908564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping and structural analysis of an anti-ErbB2 antibody A21: Molecular basis for tumor inhibitory mechanism.
    Hu S; Zhu Z; Li L; Chang L; Li W; Cheng L; Teng M; Liu J
    Proteins; 2008 Feb; 70(3):938-49. PubMed ID: 17847085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth.
    Takai N; Jain A; Kawamata N; Popoviciu LM; Said JW; Whittaker S; Miyakawa I; Agus DB; Koeffler HP
    Cancer; 2005 Dec; 104(12):2701-8. PubMed ID: 16265675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-parametric analysis reveals enhanced G2-phase arrest of an optimized anti-HER2 antibody to inhibit breast cancer.
    Qiao C; Lang X; Luo L; Geng S; Lv M; Geng J; Li X; Feng J; Shen B; Li Y
    Biotechnol Lett; 2017 Sep; 39(9):1309-1323. PubMed ID: 28560579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2.
    Jiang B; Liu W; Qu H; Meng L; Song S; Ouyang T; Shou C
    J Biol Chem; 2005 Feb; 280(6):4656-62. PubMed ID: 15536075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α.
    Ceran C; Cokol M; Cingoz S; Tasan I; Ozturk M; Yagci T
    BMC Cancer; 2012 Oct; 12():450. PubMed ID: 23033967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of peptides against HER2 with cytotoxicity on colon cancer.
    Cha N; Han X; Jia B; Liu Y; Wang X; Gao Y; Ren J
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):649-654. PubMed ID: 27068253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of evolutionarily conserved motifs of epidermal growth factor receptor 2 (HER2) predicts novel potential therapeutic epitopes.
    Deng X; Zheng X; Yang H; Moreira JM; Brünner N; Christensen H
    PLoS One; 2014; 9(9):e106448. PubMed ID: 25192037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How is Herstatin, a tumor suppressor splice variant of the oncogene HER2, regulated?
    Silipo M; Gautrey H; Satam S; Lennard T; Tyson-Capper A
    RNA Biol; 2017 May; 14(5):536-543. PubMed ID: 27935425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo design of ErbB2 epitope targeting fusion protein stabilized by coiled coil structure.
    Wang J; Feng J; Shi M; Qian L; Chen L; Yu M; Xu R; Shen B; Guo N
    Mol Immunol; 2008 Jan; 45(1):106-16. PubMed ID: 17572496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel engineered trastuzumab conformational epitopes demonstrate in vitro and in vivo antitumor properties against HER-2/neu.
    Garrett JT; Rawale S; Allen SD; Phillips G; Forni G; Morris JC; Kaumaya PT
    J Immunol; 2007 Jun; 178(11):7120-31. PubMed ID: 17513761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.
    Franklin MC; Carey KD; Vajdos FF; Leahy DJ; de Vos AM; Sliwkowski MX
    Cancer Cell; 2004 Apr; 5(4):317-28. PubMed ID: 15093539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library.
    Vaisman N; Nissim A; Klapper LN; Tirosh B; Yarden Y; Sela M
    Immunol Lett; 2000 Dec; 75(1):61-7. PubMed ID: 11163868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting HER2 Epitopes.
    Pal SK; Pegram M
    Semin Oncol; 2006 Aug; 33(4):386-91. PubMed ID: 16890794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo identification of the interaction site of ErbB2 extracellular domain with its autoinhibitor.
    Hu P; Feng J; Zhou T; Wang J; Jing B; Yu M; Hu M; Zhang X; Shen B; Guo N
    J Cell Physiol; 2005 Dec; 205(3):335-43. PubMed ID: 15920761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect of new HER2 peptide vaccination based on B cell epitope.
    Miyako H; Kametani Y; Katano I; Ito R; Tsuda B; Furukawa A; Saito Y; Ishikawa D; Ogino K; Sasaki S; Imai K; Habu S; Makuuchi H; Tokuda Y
    Anticancer Res; 2011 Oct; 31(10):3361-8. PubMed ID: 21965747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells.
    Choi BK; Fan X; Deng H; Zhang N; An Z
    Cancer Med; 2012 Aug; 1(1):28-38. PubMed ID: 23342251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action.
    DeFazio-Eli L; Strommen K; Dao-Pick T; Parry G; Goodman L; Winslow J
    Breast Cancer Res; 2011 Apr; 13(2):R44. PubMed ID: 21496232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G196 epitope tag system: a novel monoclonal antibody, G196, recognizes the small, soluble peptide DLVPR with high affinity.
    Tatsumi K; Sakashita G; Nariai Y; Okazaki K; Kato H; Obayashi E; Yoshida H; Sugiyama K; Park SY; Sekine J; Urano T
    Sci Rep; 2017 Mar; 7():43480. PubMed ID: 28266535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.